Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by rcash1on Jan 22, 2018 10:18pm
158 Views
Post# 27412906

RE:RE:RE:RE:RE:Financial Post Article

RE:RE:RE:RE:RE:Financial Post Article
Bellsey wrote: Top 5 catalysts in order of when I think they'll come ...

1) Full acquisition of Just Kush (currently at 60%) 
2) North Roads license 
3) Supply deals and or province distribution hopefully  (there will be many small ones) to distribute small growers cannabis. 
4) Just Kush License 
5) News release that LIB will open up a dispensary(ies) in Metro Vancouver . 
6) Revenue from Blockchain deal as legalization takes place 
7) Pet products come branded to market producing revenue 
8) Dealers export import licenses with affiliates in Europe
9) Uplist back to Tsx 
10) Buy out (equivalent of $2-3 a share) 

FWIW I think the pet formulations are going to be HUGE for revenue. But the above will likely happen first (well maybe not the buyout) . Let's get serious tho, Will Rascan isn't always predictable and has surprised me many times before. Maybe we buy into more private producers wih the 2 mil? I'm sure he's got a ton of buddies in the industry now. 

Also so I know some NRs are coming because they've been ignoring my email. Kris (IR girl) said she was digging around to get the info I asked, and that she needed more time. Hmm.


Ya I added a few things that might be possible as well . 
<< Previous
Bullboard Posts
Next >>